诺思格收盘上涨3.87%，滚动市盈率38.95倍，总市值55.79亿元

Group 1 - The core viewpoint of the articles highlights that Norsg has a closing price of 57.77 yuan, with a PE ratio of 38.95 times and a total market value of 5.579 billion yuan [1] - The company operates in the medical services industry, which has an average PE ratio of 47.93 times and a median of 59.03 times, placing Norsg at the 23rd position in the industry ranking [1][2] - Norsg's main business involves providing comprehensive drug clinical research and development services to global pharmaceutical companies and research institutions, including clinical trial operation services and data management [1] Group 2 - In the latest quarterly report for Q1 2025, Norsg reported an operating income of 173 million yuan, a year-on-year decrease of 2.53%, while net profit was 26.0737 million yuan, reflecting a year-on-year increase of 13.12% [1] - The company's gross profit margin stands at 36.53% [1] - On August 5, 2023, Norsg experienced a net outflow of 7.64 million yuan in principal funds, with a total outflow of 59.9384 million yuan over the past five days [1]